AGP Executive Report
Last update: 5 hours agoBiotech: Stamford-based Beeline Medicines reported Phase 2 lupus results: all three afimetoran doses beat placebo by more than 30 percentage points at 48 weeks, with no new safety signals. Utility Oversight: Connecticut is seeking a PURA investigation into utilities’ use of AI, including how systems are monitored and protected. Manufacturing: Pfizer plans a $650 million manufacturing technology center in Groton, while FuelCell Energy will host a national-lab-supported testbed for AI data-center power at its Connecticut factory. Offshore Wind: Revolution Wind is now fully operational and sending power to Connecticut, a milestone Eversource says improves its financial outlook. Solar: Connecticut marked new solar projects at the Veterans Affairs campus in Rocky Hill.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.